Search Results

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
cancer discovery
Apr 9, 2024, 05:02 | Blog
Nicholas Restifo: Advancing the Fight Against Lung Cancer with TIL Therapy
Nicholas Restifo, Chief Scientist at Marble Therapeutics, shared a post on LinkedIn: "Advancing the Fight…
Apr 8, 2024, 16:34 | Positive
Christine Lovly: A mind blowing group of past, present and future cancer scientists who have shaped the field
Christine Lovlyย shared a post on X/Twitter: โ€œFellows of the American Association for Cancer Research (AACR)…
Apr 8, 2024, 14:35 | Insight
Biagio Ricciuti: Our collaborative effort to characterize MET kinase domain mutations as novel and targetable alterations in NSCLC and other cancer types
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, posted on X: "Our collaborative effort to…
Apr 7, 2024, 23:28 | Insight
Biagio Ricciuti: MET kinase domain mutations as novel & targetable alterations in NSCLC and other cancer types
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X: "Our collaborative effort to…
Apr 7, 2024, 07:20 | Insight
Wafik El-Deiry: Dr. Alice Shaw speaks about directions in ADCโ€™s in cancer therapy at AACR 2024
Wafik El-Deiry, Director of the Legorreta Cancer Center at Brown University, recently posted on LinkedIn:…
Apr 6, 2024, 10:09 | Insight
Karen Knudsen: Today we released Global Cancer Statistics, 2024, the American Cancer Society's report on cancer trends
Quoting Karen Knudsen's post on LinkedIn: "Today we released Global Cancer Statistics, 2024, the American…
Apr 3, 2024, 15:42 | Drugs
Jarushka Naidoo: Phase II trial of Tumor-Infiltrating Lymphocyte (TIL) therapy (Lifileucel) in Advanced Non-Small Cell Lung Cancer post Immunotherapy with or without chemotherapy
Apr 2, 2024, 12:50 | Blog
Antonio Passaro: Key milestones in cancer biomarker research and future avenues for enhancing the management of patients with solid tumors
Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared a post on LinkedIn:…
Mar 28, 2024, 13:57 | Blog
Dana-Farber Cancer Institute Earns Fifth Consecutive ๐— ๐—ฎ๐—ด๐—ป๐—ฒ๐˜ยฎ Designation
Dana-Farber Cancer Instituteย made the following on LinkedIn: โ€œ๐——๐—ฎ๐—ป๐—ฎ-๐—™๐—ฎ๐—ฟ๐—ฏ๐—ฒ๐—ฟ ๐—–๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐—œ๐—ป๐˜€๐˜๐—ถ๐˜๐˜‚๐˜๐—ฒ ๐—˜๐—ฎ๐—ฟ๐—ป๐˜€ ๐—™๐—ถ๐—ณ๐˜๐—ต ๐—–๐—ผ๐—ป๐˜€๐—ฒ๐—ฐ๐˜‚๐˜๐—ถ๐˜ƒ๐—ฒ ๐— ๐—ฎ๐—ด๐—ป๐—ฒ๐˜ยฎ ๐——๐—ฒ๐˜€๐—ถ๐—ด๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป…
Mar 26, 2024, 14:54 | Dialogues
Cancer and Crisis Talks with Jemma Arakelyan #3 - Dr. Nazik Hammad
We are thrilled to unveil the next captivating episode of our enlightening series, "Cancer and…
All: 742 Posts: 251 - 260
Special Coverage